Madrigal Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: MDGLHealthcare
Live Madrigal Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
Madrigal Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$529.35Low
$537.53High
Markets Today
| Previous Close | $529.09 |
|---|---|
| Open | $537.53 |
| Volume | 58,756 |
| Day's Range | $529.35 - $537.53 |
| 52W Range | $393.61 - $615.00 |
| Market Cap | $12.09 B |
Historical Performance
| 1M Returns | +0.80 |
|---|---|
| 3M Returns | +5.85 |
| 6M Returns | +19.38 |
| 1Y Returns | +26.75 |
| 5Y Returns | +547.28 |
| 10Y Returns | +5260.59 |
Madrigal Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $12.09 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $958.40 M |
| ROE TTM | -0.42 |
| EPS TTM | $-12.87 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 23.07 |
| EBITDA | $-298.59 M |
| Profit Margin | -30.08 |
| Market Cap | $12.09 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $958.40 M |
| ROE TTM | -0.42 |
| EPS TTM | $-12.87 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 23.07 |
| EBITDA | $-298.59 M |
| Profit Margin | -30.08 |
Madrigal Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $137.25 M | $212.80 M | $287.27 M | $321.08 M | $311.34 M | $364.25 M |
| Gross Profit + | $132.74 M | $212.80 M | $287.27 M | $321.08 M | $284.49 M | $364.25 M |
| Operating Income | -$79.31 M | -$47.20 M | -$113.97 M | -$59.61 M | -$92.72 M | -$56.31 M |
| EBITDA | -$78.93 M | -$46.83 M | -$113.62 M | -$59.22 M | -$92.34 M | -$55.93 M |
| Interest Expense | -$3.30 M | -$3.26 M | -$7.45 M | -$8.30 M | -$7.82 M | -$7.94 M |
| Depreciation | $379.00 K | $377.00 K | $358.00 K | $392.00 K | $386.00 K | $381.00 K |
| Income Before Tax | -$73.24 M | -$42.28 M | -$114.19 M | -$58.58 M | -$94.39 M | -$57.94 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$73.24 M | -$42.28 M | -$114.19 M | -$58.58 M | -$94.39 M | -$57.94 M |
| Net Profit Margin | -53.36% | -19.87% | -39.75% | -18.24% | -30.32% | -15.91% |
Madrigal Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$1.88 B | -$1.92 B | -$2.03 B | -$2.09 B | -$2.18 B | -$2.24 B |
| Non-Current Liabilities | $118.75 M | $122.90 M | $345.32 M | $346.61 M | $345.61 M | $346.72 M |
| Current Liabilities | $167.24 M | $196.50 M | $391.41 M | $310.29 M | $338.26 M | $374.20 M |
| Total Liabilities | $285.99 M | $319.40 M | $736.73 M | $656.90 M | $683.87 M | $720.92 M |
| Fixed Assets | $6.54 M | $6.16 M | $10.39 M | $8.88 M | $15.32 M | $18.78 M |
| Current Assets | $987.98 M | $1.00 B | $1.35 B | $1.25 B | $1.18 B | $1.20 B |
| Total Assets | $996.63 M | $1.02 B | $1.36 B | $1.26 B | $1.23 B | $1.24 B |
Madrigal Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$73.24 M | -$42.28 M | -$114.19 M | -$58.58 M | -$94.39 M | -$57.94 M |
| Operating Cash Flow | -$88.89 M | -$47.05 M | $79.85 M | -$133.46 M | -$167.44 M | $23.33 M |
| Investing Cash Flow | $163.88 M | $47.86 M | -$207.00 M | $27.58 M | $192.19 M | $34.20 M |
| Financing Cash Flow | $8.64 M | $1.74 M | $236.65 M | $8.96 M | $2.33 M | $3.11 M |
| Change in Cash | $83.63 M | $2.55 M | $109.50 M | -$96.91 M | $28.41 M | $60.69 M |
Madrigal Pharmaceuticals, Inc. Common Stock Return Calculator
The Madrigal Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$64,923
Invested Amount$10,000
Est. Returns$54,923
About Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Popular Stocks
FAQs
What is the share price of Madrigal Pharmaceuticals, Inc. Common Stock today?
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) share price as of September 17, 2026 is $530.68. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Madrigal Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Share by opening an international trading account with Angel One.
How can I purchase Madrigal Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Madrigal Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Madrigal Pharmaceuticals, Inc. Common Stock?
The market capitalization of Madrigal Pharmaceuticals, Inc. Common Stock on September 17, 2026, is $12.09 B.
In which sector Madrigal Pharmaceuticals, Inc. Common Stock belongs?
Madrigal Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Madrigal Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
